Europe's Anduril rival Helsing raises $1.8 billion at $18 billion valuation

Helsing GmbH, a European defense-technology company, has successfully raised $1.8 billion in a new funding round. According to reports from Reuters and CNBC, this investment has placed the company's valuation at $18 billion. The funding is intended to help the company scale its AI-driven defense platform. The financial injection is described by Defense News as the largest defense-startup funding round in Europe. This significant capital increase follows a strategic internal adjustment where, as noted by Briefs Finance, the company swapped employee stock for phantom shares prior to the official raise. Major financial institutions and venture capital firms are driving this investment.

Tech Funding News specifies that Dragoneer and Lightspeed provided the capital to support the scaling of the AI platform. Additionally, Bloomberg reports that Goldman Sachs is among the backers supporting the startup, which focuses on drone technology and artificial intelligence. The breadth of coverage across marketscreener.com, Bloomberg, and Reuters emphasizes the scale of the transaction and the high valuation assigned to the group within the competitive landscape of defense technology. Contextually, Helsing is positioned as a European rival to Anduril, a prominent player in the defense-tech sector. The company's focus on an AI defense platform and drone capabilities reflects a broader trend toward integrating advanced software and autonomous systems into military infrastructure. The transition to phantom shares for employees before the raise suggests a move to manage equity structures during a period of rapid valuation growth.

This growth is occurring as European nations seek to develop domestic capabilities in AI-powered defense systems to compete with global counterparts. Future developments to monitor involve how Helsing utilizes the $1.8 billion to scale its operations and platform. The coverage indicates a focus on scaling the AI defense platform and advancing drone technology, though specific deployment timelines are not detailed. Observers will likely track whether the company maintains its trajectory as a primary European alternative to Anduril. The focus remains on the execution of its scaling strategy following this record-breaking funding round and the high valuation established by its investor group, including Goldman and Lightspeed.